@lcbnuoH Tissue accumumation studies aren‘t done on humans so who knows if the parent does get recycled several times before getting rapidly metabolized again. Radiolabeled rat studies say it doesn’t accumulate but its rats.
@lcbnuoH Abbvies EP4 is a small bet on an early stage drug with a logd very likely still substantially below 6. I am just arguing this lipophilicity point because obefazimod is indeed an extreme outlier in this regard. Doesn’t prove its toxic but it does warrant extra caution.
@lcbnuoH So that makes it an outlier amongst ARBs but it is in the same group as celecoxib, sertraline, amitriptylin, loratadine and a few more. It is an outlier but by far not as extreme as obefazimod or avacopan I believe.
@JackMan716490@deathtouch2k@seedy19tron@ScorpionFund If you have a completely new MoA I think you owe it to your patients to try the drugs first with a established safety profile and escalate quickly based on a T2T plan.
There definitely is a targeting of @seedy19tron positions, starting with @seedy19tron and @ScorpionFund butting heads over soleno. How is $abvx the company in all of XBI to target?
@JackMan716490@deathtouch2k@seedy19tron@ScorpionFund Don‘t know why you are so smug about it. Ask yourself if you would rather try a TNFi, vedolizumab and Risankizumab before trying obefazimod and the ask yourself how big this 4 th line market is. If you treated ~160 patients with hydroxychloroquin for 96 months you would likely
@JackMan716490@deathtouch2k@seedy19tron@ScorpionFund have zero symptomatic retinopathy cases. Still its a very relevant side effect. Took us >20 years after approval to understand that taking bisphosphonates too long causes atypical fractures.
@deathtouch2k@seedy19tron@ScorpionFund Avacopan also had a great label and peer reviewed journal articles. Maybe these days I want more than that from a new drug. A plausible well explored pathway, low off target risk and ideally multiple firms working on the same target, thereby validating safety and efficacy indep.
@deathtouch2k@seedy19tron@ScorpionFund Tbh for such a drug there should be more extensive clinical safety data sets than simply a 1 year phase 3 maintenance and a small phase 2 OLE. Why shouldn‘t obe be tested more extensively than icotrinra?
@deathtouch2k@seedy19tron@ScorpionFund this being a mystery compound. Hydroxychloroquin is absolutely hated by lupus patients even though it is irreplacable in treatment success, simply because it can cause retinal issues after decades that can easily be detected early. 2/3 are on it and half don‘t adhere.
@AaronRosenblum5 Not the same but this will gain traction I think. It is a mystery compound, it has a huge digital foot print on social media (a negative one by now) and UC patients are young. Certainly doesn‘t help.
@Biohazard3737 I think this shit taints obefazimods reputation. This garbage will be in the ether forever, getting recycled in patient support groups, reddit, X and regurgitated by AIs. He did the same to soleno. This should be illegal really because it puts patients health at risk.
@itchdoctor it also weeds out the dumbest ideas that were planted in patients heads by scammers. Can only hope medical ai won‘t ever be compromised by politics.
Hollywood Executives: Spider-Man 9
Twitter Auteurs: US-Nazi time-traveling war with an aerial battle over 1561 Nuremberg and occult quests to steal the Holy Lance by traveling to Elizabethan England via John Dee’s celestial communications relay.